GE HealthCare Technologies Inc.
$ 79.02
1.14%
04 Mar - close price
- Market Cap 36,013,343,000 USD
- Current Price $ 79.02
- High / Low $ 79.22 / 77.78
- Stock P/E 17.37
- Book Value 22.77
- EPS 4.55
- Next Earning Report -
- Dividend Per Share $0.14
- Dividend Yield 0.18 %
- Next Dividend Date 2026-05-15
- ROA 0.05 %
- ROE 0.22 %
- 52 Week High 89.73
- 52 Week Low 57.54
About
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Analyst Target Price
$93.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-04 | 2025-10-29 | 2025-07-30 | 2025-04-30 | 2025-02-13 | 2024-10-30 | 2024-07-31 | 2024-04-30 | 2024-02-06 | 2023-10-31 | 2023-07-25 | 2023-04-25 |
| Reported EPS | 1.29 | 1.07 | 1.06 | 1.01 | 1.57 | 1.14 | 1 | 0.9 | 1.18 | 0.99 | 0.92 | 0.85 |
| Estimated EPS | 1.41 | 1.04 | 0.92 | 0.91 | 1.26 | 1.05 | 0.98 | 0.91 | 1.07 | 0.9 | 0.87 | 0.79 |
| Surprise | -0.12 | 0.03 | 0.14 | 0.1 | 0.31 | 0.09 | 0.02 | -0.01 | 0.11 | 0.09 | 0.05 | 0.06 |
| Surprise Percentage | -8.5106% | 2.8846% | 15.2174% | 10.989% | 24.6032% | 8.5714% | 2.0408% | -1.0989% | 10.2804% | 10% | 5.7471% | 7.5949% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-05-15 | 2026-02-13 | 2025-11-14 | 2025-08-15 | 2025-05-15 | 2025-02-14 | 2024-11-15 | 2024-08-15 | 2024-05-15 | 2024-02-15 |
| Amount | $0.035 | $0.035 | $0.035 | $0.035 | $0.035 | $0.035 | $0.03 | $0.03 | $0.03 | $0.03 |
Next Dividend Records
| Dividend per share (year): | $0.14 |
| Dividend Yield | 0.18% |
| Next Dividend Date | 2026-05-15 |
| Ex-Dividend Date | 2026-04-02 |
Recent News: GEHC
2026-03-05 11:34:07
Picton Mahoney Asset Management increased its stake in Evergy Inc. by 9.7% in Q3, now owning 155,441 shares worth approximately $11.82 million. Other major institutions like Vanguard and Geode also increased their positions, contributing to 87.24% institutional ownership. Evergy declared a quarterly dividend of $0.695 per share, yielding 3.3%, and holds a "Moderate Buy" consensus rating with a target price of $86.88.
2026-03-05 10:53:18
Coherent Market Insights has released a report detailing the "Bone Densitometer Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast, 2026-2033". The report provides an in-depth analysis of market dynamics, competitive landscapes, and regional performance, offering a comprehensive decision-support tool for businesses. It covers market trends, challenges, opportunities, and includes key insights into major market players like GE HealthCare and Hologic Inc., segmented by type and application.
2026-03-05 10:19:37
Coherent Market Insights has released a new research report on the global Medical Ventilator Market, forecasting its growth until 2033. The comprehensive study analyzes market patterns, key players like Medtronic plc and Philips Healthcare, and segmentation by type, application, and region. The report aims to provide insights into market dynamics, competitive landscapes, and strategic opportunities for businesses.
2026-03-05 10:01:18
Dimensional Fund Advisors LP has increased its stake in GE HealthCare Technologies Inc. by 8.9%, now owning 5,362,717 shares valued at approximately $402.6 million. Institutional investors collectively hold 82.06% of the company's stock. GE HealthCare recently reported strong Q3 earnings, beating EPS estimates, and announced a quarterly dividend of $0.035, while analysts maintain a "Hold" rating with an average target price of $92.50.
2026-03-05 09:50:42
Dimensional Fund Advisors LP increased its stake in Motorola Solutions (NYSE:MSI) by 3.2%, acquiring an additional 28,813 shares to own a total of 925,885 shares valued at $423.4 million. This move contributes to institutional investors holding 84.17% of the company, which recently reported strong quarterly earnings, exceeding analyst expectations, and declared a quarterly dividend. Despite positive financial performance and a "Buy" consensus rating from analysts, some insider selling has occurred, including 21,600 shares sold by CEO Gregory Q. Brown.
2026-03-05 02:50:29
GE HealthCare is strengthening its imaging business through a collaboration with Gentuity LLC for cath lab imaging and new FDA clearances for AI-enabled MRI innovations like SIGNA Sprint, SIGNA Bolt, and SIGNA One. These developments aim to enhance workflow optimization and integrate advanced, sustainable technologies. The article suggests these moves reinforce GE HealthCare's product pipeline but emphasizes the ongoing importance of cash flow management and addressing tariff risks for investors.
